Madrigal Pharmaceuticals, Inc. (LSE) · Health Technology. hisse senedi canlı fiyat verisi ve teknik analiz görünümü. LSE (Londra Borsası) verilerini Alerta Chart üzerinden takip edin.
Veri erişimi kontrol ediliyor...
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Alerta Chart Pro Terminal ile aynı anda 4 grafiği takip edebilir, derinlik (order book) verilerini görebilir ve 25 aktif alarm kurabilirsiniz.
Ücretsiz Başla